Further, the integration of postoperative factors (.Ki‐67, EGFR mutation, and tumor differentiation) and Model 2 greatly improved the predictive accuracy (AUC: 0.962 in the training set and 0.942 in the validation set, p < 0.001). The gene discussed is EGFR; the disease is neoplasm.